← FDA DRUG APPROVALS

FDA ANDA · ANDA064031

AMOXICILLIN

Sponsor: TEVA

APPLICATION
ANDA064031
TYPE
ANDA
ORIGINAL APPROVAL
1996-12-19
LATEST ACTION
2000-02-02
ROUTE
ORAL
DOSAGE FORM
TABLET, CHEWABLE
MARKETING STATUS
Discontinued

Products

AMOXICILLINDiscontinued
AMOXICILLIN 125MG · TABLET, CHEWABLE · ORAL
AMOXICILLINDiscontinued
AMOXICILLIN 250MG · TABLET, CHEWABLE · ORAL

Approval history

2000-02-02Manufacturing (CMC) · Supplement 3AP
2000-02-01Labeling · Supplement 5AP
1999-07-13Labeling · Supplement 2AP
1999-07-07Labeling · Supplement 1AP
1996-12-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →